When the needs
are real, impact on
change is greater!

Air pollution and respiratory health: a multinational needs assessment of physicians

Air pollution is a major threat to human health globally, but physicians’ awareness of its specific health impacts and the extent they educate patients remain poorly understood.

Although general practitioners and pulmonologists recognise their role in assessing, managing and educating patients about air pollution exposure, their perception of this role and competencies within it indicate the need for educational support translating to impactful practice.

Read the full article: https://doi.org/10.1183/23120541.01580-2025

• NEEDS ASSESSMENT
• RESP
• 2026

A Performance and Quality Improvement Intervention Integrating Molecular Testing to Support Personalized Cancer Care in Lung and Thyroid Cancers

Molecular testing has been underutilized in the diagnosis and treatment of cancer patients, despite its potential to significantly impact clinical decision-making and resulting health outcomes.

This project aimed to evaluate the process and impact of a performance/quality improvement (PI/QI) intervention to optimize the integration of molecular testing for patients with non-small cell lung cancer (NSCLC) or thyroid cancer (TC).

 The PI/QI intervention enabled health care teams at both sites to achieve targeted changes in molecular testing, despite a busy clinical environment. These findings can serve other cancer centers aiming to increase molecular testing integration within their teams and institution.

Read the full article: https://doi.org/10.52519/ACEQI.26.2.1.a2

• Quality Improvement
• ONCO
• 2026

Knowledge, skills and attitudinal gaps in diagnosis and management of Fibrodysplasia Ossificans Progressiva in the United States

This study assesses healthcare provider knowledge, confidence, and management practices related to fibrodysplasia ossificans progressiva (FOP). Findings highlight gaps in recognition of key clinical indications, as well as challenges in patient management, referral pathways and access to specialized care.

The results underscore the need for improved rare disease recognition, multidisciplinary collaboration, and system-level approaches to support timely diagnosis and optimal patient management.

This study was made possible with the support of IPSEN Biopharmaceuticals Inc.

Read the full article: https://doi.org/10.1093/jbmrpl/ziag076

• Environmental Scan
• Rare Diseases
• 2026